article_metadata: Carlos Martínez-Chinchilla Lucía Vazquez-Montero Natalia Palazón-Carrión Isabel M Fernández-Román José López-Barba Luis de la Cruz-Merino Jesús Rodríguez-Baño Zaira R Palacios-Baena
article_metadata: 10.3389/fimmu.2022.860891
article_metadata: Front Immunol
article_metadata: 2022 Apr 14;13:860891.
article_metadata: covid-19 sars-cov-2 anti-cd20 case report immunocompromised lymphoma rituximab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/35493500/
article_metadata: COVID-19 Drug Treatment Lymphoma, B-Cell / drug therapy
article_metadata: COVID-19 Drug Treatment Lymphoma, B-Cell / drug therapy Case Reports Randomized Controlled Trial Research Support, Non-U.S. Gov't Antibodies, Monoclonal Humans Immunocompromised Host Immunosuppressive Agents Rituximab / therapeutic use SARS-CoV-2 Antibodies, Monoclonal Immunosuppressive Agents Rituximab
article_metadata: PMC9046988
article_metadata: 35493500
article_metadata: Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases
article_metadata: 2022